1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

StemoniX, Inc.

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2014

Location

Maple Grove MN US

Primary Industry

Biotechnology

About

Founded in 2014 and based in Minnesota, US, StemoniX, Inc. is a biotechnology company that offers Discovery as a Service (DaaS) program and develops human induced pluripotent stem cell (iPSC)-derived cardiac and neuronal platforms for drug discovery and drug development. Cardiac and neural cell-based toxicology experts can also use the platform to design, perform, and analyze their drug discovery and development studies.
Current Investors
Brightstone Venture Capital, Mayo Clinic Ventures, Crescent Ridge

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development, Scientific Software, Medical Software, Analytics & Performance Software
Website
www.stemonix.com
Verticals
Cloud Computing
Company Stage
Unspecified Round
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo